Related Experiment Videos
Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting
Athanasios Papathanasiou1, Ioannis K Toumpoulis, Haralampos J Milionis
1Department of Cardiology, School of Medicine, University of Ioannina, Ioannina, Greece.
Insights
Postoperative statin therapy significantly reduces long-term mortality in patients after coronary artery bypass grafting (CABG) surgery. This finding suggests statins improve survival outcomes for CABG patients.
Area of Science:
- Cardiovascular Surgery
- Pharmacology
- Clinical Outcomes Research
Background:
- Coronary artery bypass grafting (CABG) is a major cardiac surgery procedure.
- Long-term survival after CABG is influenced by various factors, including postoperative management.
- The role of statin therapy in improving outcomes post-CABG requires further investigation.
Purpose of the Study:
- To evaluate the association between postoperative statin therapy and long-term mortality.
- To assess the impact of statins on overall and cardiovascular mortality in patients after their first CABG surgery.
Main Methods:
- Observational study of 1869 patients undergoing first-time CABG.
- Follow-up over 17 years, with Cox proportional hazard analysis and Kaplan-Meier survival curves.
- Adjusted for multiple confounding factors including age, comorbidities, and treatment regimens.
Main Results:
- 48% of patients received postoperative statin therapy.
- Statin use was associated with a significant reduction in total mortality (aHR 0.48) and cardiovascular mortality (aHR 0.43).
- Survival curves diverged around 2 years post-surgery, indicating sustained benefit.
Conclusions:
- Postoperative statin therapy is linked to a 50% reduction in mortality after first-ever CABG.
- These findings highlight the potential benefit of statins in improving long-term outcomes for CABG patients.
- Observational data suggests statins are a valuable adjunct in managing patients post-cardiac surgery.
Objective:
In an observational study, we evaluated the association between postoperative statin therapy and long-term mortality among patients undergoing a first-ever coronary artery bypass grafting (CABG) surgery.
Methods:
In an outpatient clinic setting, we assessed 1869 consecutive patients (age 58.7+/-9.6 years; 1657 men), who survived the 1st month after a first-ever CABG, within a 17-year period. Cox proportional hazard analysis was used to calculate the adjusted hazard ratios (adjusting for age, smoking, the presence of hypertension, diabetes mellitus, lipid profile at the time of the procedure, vessel disease, number and kind of grafts used, and concomitant treatment) for patients receiving statin treatment during follow-up and adjusted Kaplan-Meier survival curves were constructed.
Results:
During a 9345 patient-years follow-up, 48% of the patients were on a statin. In a total of 222 deaths, 80.6% were because of cardiovascular causes. Total and cardiovascular mortality were significantly reduced in patients receiving statin therapy [adjusted hazard ratio, 0.48 (95% confidence interval, 0.28-0.82); P=0.007), and 0.43 (95% confidence interval, 0.23-0.80); P=0.007, respectively]. The estimated 16-year Kaplan-Meier survival curves diverged at 2 years and thereafter.
Conclusion:
Taking into account the potential limitations of observational data, statin treatment postoperatively is associated with a 50% reduction in total and cardiovascular mortality in patients undergoing a first-ever CABG.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Peripheral Artery Disease V: Postoperative Nursing Management